The financial future of California’s $3 billion human embryonic stem cell research institute went on trial Monday as taxpayer groups tried to block the state-funded research.

Two lawsuits seek to invalidate the law that created the California Institute of Regenerative Medicine, which is authorized to hand out an average of $300 million in research grants annually. The lawsuits claim the agency violates a constitutional mandate that the state control spending of taxpayer dollars.